• CRISPR Therapeutics (NASDAQ:CRSP) Given New $56.00 Price Target at Barclays

    Source: Buzz FX / 13 Feb 2025 07:21:11   America/New_York


    CRISPR Therapeutics (NASDAQ:CRSP) Given New $56.00 Price Target at Barclays Written by MarketBeat February 13, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Free Report ) had its price objective raised by Barclays
    Read more...
Share on,